Browsing: Therapeutics

This is a paid press release. Contact the press release distributor directly with any enquiries.

This is a paid press release. Contact the press release distributor directly with any inquiries.

This is a paid press release. Contact the press release distributor directly with any inquiries.

This is a paid press release. Contact the press release distributor directly with any inquiries.

Arctic Therapeutics has raised an oversubscribed $21.5 million financing round to advance two additional pipeline programs toward clinical development while continuing partnering and out-licensing efforts for its lead clinical-stage assets. The financing was led by investment firm Pekron, Investcorp-backed Sanos Group, Icelandic investment company Kaldbakur, and Landvættir, an Icelandic venture capital fund managed by AxUM…

This is a paid press release. Contact the press release distributor directly with any inquiries.

This is a paid press release. Contact the press release distributor directly with any inquiries.

Japanese startup Celaid Therapeutics Inc. has announced the completion of the second close of its Series B financing round. The round welcomed Shionogi & Co., Ltd. and Teikoku Ventures, Inc. as new investors, raising a total of JPY 400 million (approximately $2.6 million).

Aptadir Therapeutics, a biotech company developing a new class of RNA inhibitor-based therapies for the treatment of intractable genetic disorders, has announced that it has closed a seed funding round worth 40 million euros.

Calif., Sept. 25, 2026/PRNewswire/ –KaliTherapeutics, a clinical-stage biotechnology company pioneering next-generation immune-resetting and multi-specific therapies, today announced its selection as a winner of the 2026 Endpoints 11, the annual list of the 11 most promising private biotechnology companies curated by the Endpoints News editorial team